KATELYN LANGE: Open Payments
NPI 1144892910 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 39 payments from 17 companies in 2025. Trend: 2023 $1,824 · 2024 $1,758 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $222 |
| Janssen Biotech, Inc. | 3 | $175 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $93 |
| PFIZER INC. | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| GENZYME CORPORATION | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Almirall LLC | 1 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $26 |
Products named: TREMFYA, RINVOQ, DUPIXENT, CIBINQO, Sotyktu, BOTOX, ILUMYA, Winlevi.
Industry payments across MI — which companies pay providers there.
